Advertisement

Baseline Bone Pain Associated With Worse Survival in Metastatic Prostate Cancer

Apr 03, 2024

REFERENCES & ADDITIONAL READING

Gebreal G, et al. Baseline bone pain as a prognostic marker for survival for men with metastatic hormone-sensitive prostate cancer (mHSPC): Patient-level analysis of SWOG 1216 trial. Abstract presented at: 2024 ASCO Genitourinary Cancers Symposium; January 25-27, 2024; San Francisco, CA.

ABOUT THE EXPERTS

Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement